For the financial period ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

I-solutions Global Limited is a private company limited by shares incorporated in England and Wales. The registered office is 27-28, Eastcastle Street, London, W1W 8DH. The company's principal activities and nature of it's operations are disclosed in the directors' report.

These financial statements have been prepared for the period from 21 January 2025 to 30 September 2025. The previous accounts filed were for the period from 1 October 2023 to 20 January 2025 and therefore are not entirely comparable.

The change in the current accounting period is to align with the financial statements of i-nexus Global Limited, the parent company, and re-align with the company's former year end of 30 September.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

These financial statements for the period ended 30 September 2025 are the first financial statements of I-solutions Global Limited prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 21 January 2025. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102. The company has not used any practical expedients offered by section 35 of FRS 102 as part of its transition to being a first time preparer under FRS 102.

The company has incurred losses to date, primarily due to investment in new product development, and is currently operating under cash flow constraints.true

The directors have undertaken a strategic review of the business and are refocusing development efforts on the company’s core product to support customer demand and revenue growth within established markets.

The directors have prepared cash flow forecasts for a period of at least 12 months from the date of approval of these financial statements. These forecasts indicate that the company will need to carefully manage its cash resources and achieve its forecast revenues.

These conditions indicate the existence of a material uncertainty which may cast significant doubt on the company’s ability to continue as a going concern. The financial statements have nevertheless been prepared on a going concern basis, as the directors have reasonable expectation that the actions taken will enable the company to continue in operational existence for the foreseeable future.

The financial statements do not include any adjustments that would result if the company were unable to continue as a going concern.

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Accrued revenue represents income recognised in respect of goods or services transferred to customers before the Company has an unconditional right to invoice the customer. Accrued revenue is measured at the amount of consideration expected to be received and is included within debtors.

The company recognises revenue from the following major sources:

• Licence fee income (on a SaaS basis)

• Professional services

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue for annual licences, support and maintenance is recognised on a straight-line basis over the duration of the contract.

Configuration and software customisation revenue is recognised on a percentage completion basis over the period during which the configuration or software customisation is completed, in line with FRS 102 Section 23. Setup, deployment, migration and report development revenue are recognised at the point of setup, deployment, migration or report development is completed. In circumstances where an event spans two or more accounting periods, the revenue is recognised in the period when the event is completed and the software has been accepted by the customer. Revenue for training events is recognised at the point the training event is completed.

Payment terms are agreed on a contract by contract basis.

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Research expenditure is recognised as an expense when it is incurred. Development expenditure is recognised as an expense except that costs incurred on development projects are capitalised as intangible assets to the extent that such expenditure is expected to generate future economic benefit.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit and loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Intangible assets with indefinite useful lives and intangibles assets not yet available for use are tested for impairment annually, and whenever there is an indication that an asset may be impaired.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Share capital represents the nominal value of shares that have been issued.

Share premium includes all current and prior period premiums on shares allotted.

Capital redemption reserve represents the value of share capital redeemed.

Capital contribution reserve represents the transfer of share option costs from the parent company where i-solutions Global Limited is the employer and primary recipient of the benefit of the employment of those staff.

Retained earnings include all current and prior period retained earnings.

The tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

The company has elected not to recognise right-of-use assets and lease liabilities for short-term leases of machinery that have a lease term of 12 months or less, or for leases of low-value assets including IT equipment. The payments associated with these leases are recognised in profit or loss on a straight-line basis over the lease term.

Where the Company receives research and development expenditure credits (“RDEC”) it accounts for these as government grant income within operating income as it more closely aligns with grant income as opposed to a taxation credit. The income is recognised on a systematic basis over the periods in which the entity recognises expenses for the related costs for which the grants are intended to compensate. The amounts recognised represent the gross receipt of RDEC, which is a taxable income.

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

The subsidiary has sustained losses and the balance sheet is in a deficit. This is an indicator of potential impairment. The recoverability of the intercompany debtor and the cost of investment is dependent on the future profitability of the entity, as whilst the debtor is repayable on demand the directors are intending to allow the subsidiary to continue to trade in order to generate sufficient profits and cash to render this balance recoverable. A provision for impairment of £11,660 (20 January 2025 - £nil) has been made and is a significant judgement, as explained in . As at the year-end the accumulated impairment charged to date is £1,173,914 (20 January 2025 - £1,162,254).

Development expenditure is capitalised where the directors are satisfied that the project is technically feasible, commercially viable and will generate probable future economic benefits. Capitalised development costs are amortised on a straight-line basis over their estimated useful economic lives and are reviewed for impairment where indicators exist.

Amortisation is provided so as to write down the development costs capitalised to their residual values over their estimated useful lives as set out in the company's accounting policy. The selection of estimated useful life requires the exercise of management judgement. Useful lives are regularly reviewed and should management's assessment of useful lives shorten/increase then amortisation charges in the financial statements would increase/decrease and carrying amounts of intangible assets would change accordingly.

During the year, the directors considered the recoverability of the capitalised development costs, which are included in its balance sheet at £709,684 (20 January 2025 - £622,220) after impairment. For individual assets not yet available for use or where indicators of impairment existed, the directors carried out a net present value assessment of the future expected revenue and net profit stream over a 5 year period, using the forecasts for the company's performance. Based on this estimate the directors are satisfied that there is no impairment of the assets.

The revenues and costs included in the forecasts, the discount rate used, and the growth rates applicable are the key inputs to the value in use model.

The average monthly number of persons (including directors) employed by the company during the period was:

The useful economic life of each of the individual assets is deemed to be 5 years. The additions in the year of £237,795 relate to specific products being developed. These products are deemed to provide future economic benefits to the company.

Included within the above are intangible assets which remain under development as at the year end with a cost of £147,093 (January 2025 - £nil). These assets are not being amortised until completed and brought into use.

Additions in the year represent internally generated intangible assets for time incurred by employees of the company. All amounts capitalised represent the relevant portion of an individual's total salary costs spent on qualifying development projects.

The directors consider that the carrying amounts of financial assets carried at amortised cost in the financial statements approximate to their fair values.

Details of the company's subsidiaries at 30 September 2025 are as follows:

There are no significant or unusual payment terms associated with contract assets.

Contract liabilities relate to deferred revenue which is due to unwind within 12 months. The company recognises its revenues over time and therefore the ongoing provision of services is expected to establish the company's entitlement to these revenues.

Amounts owed by subsidiary undertakings are non-interest bearing and repayable on demand. This balance is stated after a provision for bad and doubtful debts amounting to £1,173,914 (20 January 2025 - £1,162,254).

Trade payables are non-interest bearing and are normally settled on 60 day terms. The company has a financial risk management policy in place to ensure that all payables are paid within the pre-agreed credit terms.

Amounts owed to the parent undertaking are non-interest bearing and repayable on demand.

Bank loans are secured by way of a fixed charge over the cash deposits of the company.

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

The company has tax losses of £9,861,876 (January 2025 - £9,993,333) of which £9,167,740 (January 2025 - £9,399,912) have not been recognised as a deferred tax asset due to uncertainty over the timing and extent of the company's ability to utilise these against future taxable profits. Recognised deferred tax assets have been included only to the extent that these offset other temporary timing differences which will unwind against the losses. If a deferred tax asset was recognised in full in respect of this, the company's net assets would increase by £2,291,935 (January 2025 - £2,349,978). Tax losses have no date of expiry or unusual restrictions on utilisation.

Total expenses of £nil (20 January 2025 - £2,157) relating to equity-settled share-based payment transactions were recognised in the year.

The fair value expense relates to options granted to employees of the company but are for issue of shares in i-nexus Global Limited (formerly i-nexus Global Plc), the company's immediate and ultimate parent.

The following amounts were recognised as an expense in the period in respect of bad and doubtful debts due from related parties:

The company has taken advantage of the exemptions conferred by s33.1A of FRS 102 which permits it to not disclose transactions with wholly owned group companies.

The immediate and ultimate parent company is i-nexus Global Limited. The smallest and largest group into which these financial statements are consolidated is i-nexus Global Limited. Copies of the consolidated financial statements can be obtained from its registered office: 27-28 Eastcastle Street, London, W1W 8DH.